Also, sEV-AnxA2 protein leads to mesothelial-mesenchymal transition by degradation of the extracellular matrix in the tumor microenvironment to create a pre-metastatic niche for ovarian cancer development through the PI3K/Akt/mTOR pathway [34]. This evidence concerns the gene ANXA2 and neoplasm.